Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE

BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE

Standard Dose
0.75%;0.005MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE is listed in Drugs@FDA under application 071171 (ANDA).

Marketing status: Discontinued Active ingredient BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE Form and strength INJECTABLE;INJECTION - 0.75%;0.005MG/ML Sponsor HOSPIRA Submission history Latest submission status date: 2002-12-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE is listed in Drugs@FDA under application 071171 (ANDA). Marketing status: Discontinued Active ingredient BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE Form and strength INJECTABLE;INJECTION - 0.75%;0.005MG/ML Sponsor HOSPIRA Submission history Latest submission status date: 2002-12-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.